Portugal: An Uptick In Life Science VC Funding
An international VC, Vesalius Biocapital, is to invest in start-up life sciences and biotech companies in the western European country that is developing an entrepreneurial ecosystem.
You may also be interested in...
European fund manager Vesalius has closed its third fund with €120m. Its managers believe their strategy of investing in maturing companies has been the key to attracting commitments, including from the European Investment Fund.
Market conditions in Portugal are continuing to deteriorate as cost cutting has fuelled parallel exports and hospitals owe companies increasingly more money, APIFARMA, the local R&D-based pharmaceutical industry association, has warned.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.